Type 2 diabetes is a progressive disease and most patients will eventually need insulin to achieve euglycemia. Early and aggressive management to lower blood glucose reduces the risk of complications of the disease. It can be challenging for health care professionals to decide which treatment regimen is appropriate to manage a particular patient. Join host Dr. Steven Edelman and his guest, endocrinologist and medical advisor to the Charles H. Best Diabetes Centre in Ontario, Canada, Dr. Ian Blumer, as they discuss insulin initiation strategies.
Toward Safe and Effective Insulin Initiation
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Type 2 diabetes is a progressive disease and most patients will eventually need insulin to achieve euglycemia. Early and aggressive management to lower blood glucose reduces the risk of complications of the disease. It can be challenging for health care professionals to decide which treatment regimen is appropriate to manage a particular patient. Join host Dr. Steven Edelman and his guest, endocrinologist and medical advisor to the Charles H. Best Diabetes Centre in Ontario, Canada, Dr. Ian Blumer, as they discuss insulin initiation strategies.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
1.00 credits
<p>Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring</p>
MinuteCE®
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
1.00 credits
<p>Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D</p>
MinuteCE®
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
0.50 credits
<p>What do we know now that could have changed the history of CETP inhibition?: genetics and biology </p>
CME/CE Broadcast Replay
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
1.00 credits
<p>Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates</p>
CME/CE
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
<p>AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care</p>
NeuroFrontiers
mIDH Gliomas Explained: Characteristics and Management Strategies
<p>mIDH Gliomas Explained: Characteristics and Management Strategies</p>
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
<p>From Diagnosis to Treatment: Challenges in Glioblastoma Care</p>
Clinician's Roundtable
Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder
<p>Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?